ARCHIVES

California Weighs Listing Tamoxifen As Carcinogen

This article is from The Cancer Letter archive.

Vol. 21 No. 41 | October 27, 1995

Download PDF Visit The Full Archive

Related Articles

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008

ACCC Enthusiastically Support New Effort Or Clinical Research

April 3, 1981

Clinical Oncology Program Has Top Priority Fink Says

February 9, 1979

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

October 28, 2011

In Brief: George Santos Wins Bristol-Meyers Award; SG Elects William Creasman President; Levin To MDA

April 1, 1988

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993